Literature DB >> 14354890

[Hormonal effect of parotid glands on protein metabolism. II. Parotin therapy of myasthenia gravis].

Y TAKAOKA, M UONO, H NINOMIYA, M YOSHIKAWA, N YAMADA, T ISHKAWA.   

Abstract

Entities:  

Keywords:  MYASTHENIA GRAVIS/therapy; PAROTID GLAND; TISSUE EXTRACTS/therapeutic use

Mesh:

Substances:

Year:  1955        PMID: 14354890     DOI: 10.1007/bf01467295

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


× No keyword cloud information.
  8 in total

1.  Octamethyl pyrophosphoramide in treatment of myasthenia gravis: further observations.

Authors:  S SCHULMAN; J A RIDER; R B RICHTER
Journal:  AMA Arch Neurol Psychiatry       Date:  1953-05

2.  EFFECT OF BLOOD SERUM FROM PATIENTS WITH MYASTHENIA GRAVIS ON THE SYNTHESIS OF ACETYLCHOLINE IN VITRO.

Authors:  C Torda; H G Wolff
Journal:  J Clin Invest       Date:  1944-09       Impact factor: 14.808

3.  Observations of the effects of tetraethyl pyrophosphate in man, and on its use in the treatment of myasthenia gravis.

Authors:  D GROB; A M HARVEY
Journal:  Bull Johns Hopkins Hosp       Date:  1949-06

4.  THE THYMUS AND ACETYLCHOLINE SYNTHESIS.

Authors:  J H Welsh; J E Hyde
Journal:  Science       Date:  1945-09-07       Impact factor: 47.728

5.  THE NATURE OF MYASTHENIA GRAVIS.

Authors:  H C Stoerk; E Morpeth
Journal:  Science       Date:  1944-06-16       Impact factor: 47.728

6.  Effects of corticotropin (ACTH) and cortisone on disorders of the nervous system.

Authors:  G H GLASER; H H MERRITT
Journal:  J Am Med Assoc       Date:  1952-03-15

7.  The analysis of muscle action potentials in the differential diagnosis of neuromuscular diseases.

Authors:  A T RICHARDSON
Journal:  Arch Phys Med Rehabil       Date:  1951-04       Impact factor: 3.966

8.  Effects of administration of the adrenocorticotropic hormone on patients with myasthenia gravis.

Authors:  C TORDA; H G WOLFF
Journal:  AMA Arch Neurol Psychiatry       Date:  1951-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.